For the year ending 2025-12-31, MLYS has $661,806K in assets. $172,921K in cash and cash equivalents.
| Balance Sheets | 2025-12-31 | |||
|---|---|---|---|---|
| Cash and cash equivalents | 172,921 | |||
| Investments | 483,714 | |||
| Prepaid and other current assets | 4,751 | |||
| Total current assets | 661,386 | |||
| Property and equipment, net | 38 | |||
| Other assets | 382 | |||
| Total assets | 661,806 | |||
| Accounts payable | 2,017 | |||
| Accrued liabilities | 13,096 | |||
| Total current liabilities | 15,113 | |||
| Common stock, 0.0001 par value 500,000,000 shares authorized as of december31, 2025 and 2024 81,536,557 and 49,821,915 shares issued and outstanding as of december31, 2025 and 2024, respectively | 8 | |||
| Additional paid-in capital | 1,103,854 | |||
| Accumulated deficit | -457,169 | |||
| Total stockholders equity | 646,693 | |||
| Total liabilities and stockholders equity | 661,806 | |||
Mineralys Therapeutics, Inc. (MLYS)
Mineralys Therapeutics, Inc. (MLYS)